Hemocrit 2000 IU (IV/SC Injection)
2000 IU pre-filled syringe: ৳ 1,000.00
Medicine Details
Category | Details |
---|---|
Generic | Erythropoietin alfa |
Company | Eskayef pharmaceuticals ltd |
Also available as |
Indications
- Treatment of anemia in Chronic Kidney Disease (CKD)
- Treatment of anemia in Zidovudine-treated HIV-infected patients
- Treatment of anemia in patients undergoing myelosuppressive chemotherapy
- Reduction of allogeneic RBC transfusions in elective surgery patients
- Prevention of anemia of prematurity in infants
Description
- Recombinant human erythropoietin (EPO)
- Expressed in Chinese hamster ovary cells
- Identical to human urinary EPO in amino acid sequence
- Apparent molecular weight of erythropoietin: 30,400 daltons
Dosage
- Evaluation of Iron Stores and Nutritional Factors
- Monitoring hemoglobin levels
- Dosing adjustments based on hemoglobin levels
- Initiating treatment based on hemoglobin levels in CKD patients
- Dose adjustment for Zidovudine-treated HIV-infected Patients
- Initiating Erythropoietin alfa in cancer patients on chemotherapy
- Dosing administration for prevention of anemia of prematurity
Administration
- Preparation and administration procedures
- Avoid shaking or freezing the product
- Visual inspection for particulate matter and discoloration
- Discard unused portions
Interaction
- Effect potentiation with haematinic agents like ferrous sulphate
Contraindications
- Uncontrolled hypertension
- Serious allergic reactions to Erythropoietin alfa
- Pure Red Cell Aplasia (PRCA) following treatment with any erythropoietin
Side Effects
- Adverse reactions in CKD patients
- Adverse reactions in Zidovudine-treated HIV-infected Patients
- Adverse reactions in Cancer Patients on Chemotherapy
- Adverse reactions in Surgery Patients
- Adverse reactions in Premature infants
Pregnancy & Lactation
- Use in pregnant women
- Use in pregnant or lactating surgical patients participating in an autologous blood predonation programme
Overdose Effects
- Causes hemoglobin levels above the desired level
- Management of overdosage with discontinuation or reduction of dosage
- Cases of severe hypertension observed following overdose
Therapeutic Class
- Drugs for Haemolytic, Hypoplastic & Renal Anemia
Storage Conditions
- Temperature range for storage: 2°C to 8°C
- Avoid freezing or shaking
- Storage in original package to protect from light
Related Brands
- Hemocrit 3000 IU (IV/SC Injection) - eskayef-pharmaceuticals-ltd
- Hemocrit 5000 IU (IV/SC Injection) - eskayef-pharmaceuticals-ltd
- Eporise 2000 IU (IV/SC Injection) - ziska-pharmaceuticals-ltd
- Eporise 3000 IU (IV/SC Injection) - ziska-pharmaceuticals-ltd
- Eporise 5000 IU (IV/SC Injection) - ziska-pharmaceuticals-ltd